281 – 300 of 304
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice
(
- Contribution to journal › Article
-
Mark
Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients
(
- Contribution to journal › Article
- 2000
-
Mark
Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases
(
- Contribution to journal › Article
-
Mark
Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma
(
- Contribution to journal › Article
-
Mark
TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD
(
- Contribution to journal › Article
-
Mark
CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
(
- Contribution to journal › Article
-
Mark
No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression
(
- Contribution to journal › Article
-
Mark
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
(
- Contribution to journal › Article
-
Mark
Nya rön om Alzheimers sjukdom: Gott hopp om att biokemiska markörer kan skärpa diagnostiken
(
- Contribution to journal › Article
- 1999
-
Mark
Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
(
- Contribution to journal › Article
- 1998
-
Mark
Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease
(
- Contribution to journal › Article
- 1997
-
Mark
The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease
(
- Contribution to journal › Article
-
Mark
Somatostatin and neuropeptide Y in cerebrospinal fluid: correlations with severity of disease and clinical signs in Alzheimer's disease and frontotemporal dementia
(
- Contribution to journal › Article
- 1996
-
Mark
Correlation between clinical characteristics and cerebrospinal fluid neuropeptide Y levels in dementia of the Alzheimer type and frontotemporal dementia
(
- Contribution to journal › Article
- 1995
-
Mark
Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease
(
- Contribution to journal › Article
- 1994
-
Mark
Tacrine treatment modifies cerebrospinal fluid neuropeptide levels in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Neuropsychological tests as discriminators between dementia of Alzheimer type and frontotemporal dementia
(
- Contribution to journal › Article
- 1993
-
Mark
Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration
(
- Contribution to journal › Article